Abstract
The highlight of the 2008 Conference on Retroviruses and Opportunistic Infections was a sober assessment of the HIV vaccine field by one of its pioneers. Desrosiers delivered a plenary session in which he called for refocusing our HIV vaccine effort. He suggested that none of the current vaccine candidates in human clinical trials stands a chance against HIV. Thus, we need to redirect our efforts to basic vaccine research. This call for a sea change in how we carry out HIV vaccine research has already had an impact, prompting a recent HIV vaccine summit in Bethesda, MD. This will likely herald a new era in HIV vaccine research, resulting in a redoubling of effort to uncover innovative new ways of making an HIV vaccine.
Original language | English (US) |
---|---|
Pages (from-to) | 7-8 |
Number of pages | 2 |
Journal | Topics in HIV medicine : a publication of the International AIDS Society, USA |
Volume | 16 |
Issue number | 1 |
State | Published - Jan 1 2008 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)